However, GAS6 levels were lower in patients with milder acute COVID-19 and in post–COVID-19 subjects in whom acute inflammation had resolved, compared with healthy donors and patients with severe COVID-19 (Figure 3B). This evidence concerns the gene GAS6 and COVID-19.